BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26216510)

  • 1. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
    Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
    Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
    Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
    Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
    Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line.
    Caetano-Pinto P; Janssen MJ; Gijzen L; Verscheijden L; Wilmer MJ; Masereeuw R
    Mol Pharm; 2016 Mar; 13(3):933-44. PubMed ID: 26871298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide.
    Quan E; Wang H; Dong D; Zhang X; Wu B
    Drug Metab Dispos; 2015 Apr; 43(4):433-43. PubMed ID: 25595598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered kidney tubules efficiently excrete uremic toxins.
    Jansen J; Fedecostante M; Wilmer MJ; Peters JG; Kreuser UM; van den Broek PH; Mensink RA; Boltje TJ; Stamatialis D; Wetzels JF; van den Heuvel LP; Hoenderop JG; Masereeuw R
    Sci Rep; 2016 May; 6():26715. PubMed ID: 27242131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
    Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
    Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
    Mutsaers HA; van den Heuvel LP; Ringens LH; Dankers AC; Russel FG; Wetzels JF; Hoenderop JG; Masereeuw R
    PLoS One; 2011 Apr; 6(4):e18438. PubMed ID: 21483698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue.
    Jansen J; Schophuizen CMS; Wilmer MJ; Lahham SHM; Mutsaers HAM; Wetzels JFM; Bank RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
    Exp Cell Res; 2014 Apr; 323(1):87-99. PubMed ID: 24560744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.
    Zhou X; Wang S; Sun H; Wu B
    Drug Metab Pharmacokinet; 2015 Dec; 30(6):425-33. PubMed ID: 26611713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
    Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
    Caetano-Pinto P; Jamalpoor A; Ham J; Goumenou A; Mommersteeg M; Pijnenburg D; Ruijtenbeek R; Sanchez-Romero N; van Zelst B; Heil SG; Jansen J; Wilmer MJ; van Herpen CML; Masereeuw R
    Mol Pharm; 2017 Jun; 14(6):2147-2157. PubMed ID: 28493713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide.
    Hasegawa M; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
    J Am Soc Nephrol; 2007 Jan; 18(1):37-45. PubMed ID: 17135398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
    Järvinen E; Troberg J; Kidron H; Finel M
    Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter.
    Lu D; Dong D; Xie Q; Li Z; Wu B
    Drug Metab Dispos; 2018 Jul; 46(7):970-979. PubMed ID: 29691239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells.
    Lu Y; Nakanishi T; Hosomi A; Komori H; Tamai I
    J Pharm Pharmacol; 2015 Feb; 67(2):170-7. PubMed ID: 25515305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.
    Brand W; Oosterhuis B; Krajcsi P; Barron D; Dionisi F; van Bladeren PJ; Rietjens IM; Williamson G
    Biopharm Drug Dispos; 2011 Dec; 32(9):530-5. PubMed ID: 22083890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
    Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
    Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP).
    Dankers AC; Mutsaers HA; Dijkman HB; van den Heuvel LP; Hoenderop JG; Sweep FC; Russel FG; Masereeuw R
    Biochim Biophys Acta; 2013 Oct; 1832(10):1715-22. PubMed ID: 23665398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.